Epigenetic Regulation of Aldosterone Synthase Gene by Sodium and Angiotensin II

Background DNA methylation is believed to be maintained in adult somatic cells. Recent findings, however, suggest that all methylation patterns are not stable. We demonstrate that stimulatory signals can change the DNA methylation status around transcription factor binding sites and a transcription start site and activate expression of the aldosterone synthase gene (CYP11B2). Methods and Results DNA methylation of CYP11B2 was analyzed in aldosterone‐producing adenomas, nonfunctioning adrenal adenomas, and adrenal glands and compared with the gene expression levels. CpG dinucleotides in the CYP11B2 promoter were found to be hypormethylated in tissues with high expression, but not in those with low expression, of CYP11B2. Methylation of the CYP11B2 promoter fused to a reporter gene decreased transcriptional activity. Methylation of recognition sequences of transcription factors, including CREB1, NGFIB (NR4A1), and NURR1 (NR4A2) diminished their DNA‐binding activity. A methylated‐CpG‐binding protein MECP2 interacted directly with the methylated CYP11B2 promoter. In rats, low salt intake led to upregulation of CYP11B2 expression and DNA hypomethylation in the adrenal gland. Treatment with angiotensin II type 1 receptor antagonist decreased CYP11B2 expression and led to DNA hypermethylation. Conclusions DNA demethylation may switch the phenotype of CYP11B2 expression from an inactive to an active state and regulate aldosterone biosynthesis.

[1]  C. Gomez-Sanchez,et al.  Hypomethylation of CYP11B2 in Aldosterone-Producing Adenoma , 2016, Hypertension.

[2]  M. Suematsu,et al.  Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism. , 2016, The Journal of clinical endocrinology and metabolism.

[3]  Caiyu Chen,et al.  Differential expression and DNA methylation of angiotensin type 1A receptors in vascular tissues during genetic hypertension development , 2015, Molecular and Cellular Biochemistry.

[4]  Yonghong Wang,et al.  Integrated analysis of genome-wide methylation and gene expression shows epigenetic regulation of CYP11B2 in aldosteronomas. , 2014, The Journal of clinical endocrinology and metabolism.

[5]  Yuan Cheng,et al.  Dynamic CCAAT/Enhancer Binding Protein–Associated Changes of DNA Methylation in the Angiotensinogen Gene , 2014, Hypertension.

[6]  T. Seki,et al.  Sodium deficiency regulates rat adrenal zona glomerulosa gene expression. , 2014, Endocrinology.

[7]  J. Torchia,et al.  TGF-β-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217/CoREST complex. , 2012, Molecular cell.

[8]  H. Shibuya,et al.  DNA demethylation for hormone-induced transcriptional derepression , 2011, Nature.

[9]  Katsutoshi Takahashi,et al.  Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009. , 2011, Endocrine journal.

[10]  P. Defossez,et al.  The Human Proteins MBD5 and MBD6 Associate with Heterochromatin but They Do Not Bind Methylated DNA , 2010, PloS one.

[11]  Ping Ye,et al.  Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells. , 2009, Endocrinology.

[12]  S. Bulun,et al.  CpG dinucleotide methylation of the CYP19 I.3/II promoter modulates cAMP-stimulated aromatase activity , 2008, Molecular and Cellular Endocrinology.

[13]  I. Bogdarina,et al.  Epigenetic Modification of the Renin-Angiotensin System in the Fetal Programming of Hypertension , 2007, Circulation research.

[14]  A. Bird,et al.  DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. , 2005, Molecular cell.

[15]  Takashi Suzuki,et al.  Nur-related factor 1 and nerve growth factor-induced clone B in human adrenal cortex and its disorders. , 2004, The Journal of clinical endocrinology and metabolism.

[16]  Takashi Suzuki,et al.  The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production. , 2004, Molecular endocrinology.

[17]  T. Saruta,et al.  COUP‐TF and Transcriptional Co‐Regulators in Adrenal Steroidogenesis , 2004, Endocrine research.

[18]  H. Mabuchi,et al.  Completely skewed X-inactivation in a mentally retarded young female with pseudohypoparathyroidism type IB and juvenile renin-dependent hypertension. , 2003, The Journal of clinical endocrinology and metabolism.

[19]  J. Connell,et al.  Regulation of aldosterone synthase gene expression in the rat adrenal gland and central nervous system by sodium and angiotensin II. , 2003, Endocrinology.

[20]  H. Mabuchi,et al.  Calcineurin Inhibition Attenuates Mineralocorticoid-Induced Cardiac Hypertrophy , 2002, Circulation.

[21]  I. Miyamori,et al.  Cardiac Aldosterone Production in Genetically Hypertensive Rats , 2000, Hypertension.

[22]  A. Bird,et al.  Identification and Characterization of a Family of Mammalian Methyl-CpG Binding Proteins , 1998, Molecular and Cellular Biology.

[23]  J. Mathis,et al.  Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements. , 1997, Molecular endocrinology.